↓ Skip to main content

Tetraspanin 7 autoantibodies in type 1 diabetes

Overview of attention for article published in Diabetologia, May 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
49 Mendeley
Title
Tetraspanin 7 autoantibodies in type 1 diabetes
Published in
Diabetologia, May 2016
DOI 10.1007/s00125-016-3997-1
Pubmed ID
Authors

Denise Walther, Anne Eugster, Sibille Jergens, Anita Gavrisan, Christina Weinzierl, Tanja Telieps, Christiane Winkler, Anette G. Ziegler, Ezio Bonifacio

Abstract

Autoantibodies to pancreatic beta cell proteins are markers of asymptomatic type 1 diabetes. The aim was to determine whether autoantibodies to the beta cell protein tetraspanin 7 would improve the ability to identify autoimmunity against pancreatic beta cells. Full length and external domain fragments of tetraspanin 7 were expressed as luciferase-tagged fusion proteins and used in immunoprecipitation assays to measure autoantibodies in samples from 363 patients with type 1 diabetes at onset of disease, 503 beta cell autoantibody negative first-degree relatives of patients, and 212 relatives with autoantibodies to insulin, glutamic acid decarboxylase, insulinoma antigen 2 or zinc transporter 8. Antibody binding was observed against the full length and external domains of tetraspanin 7, and was strongest against the full length protein. Autoantibodies that could be inhibited by untagged tetraspanin 7 were detected in 5 (1%) of 503 autoantibody negative relatives, 3 (3.2%) of 94 autoantibody negative patients, 95 (35.3%) of 269 autoantibody positive patients, 1 (1%) of 98 single autoantibody positive relatives and 25 (21.9%) of 114 multiple autoantibody positive relatives. Progression to diabetes did not differ between multiple autoantibody positive relatives with and without tetraspanin 7 autoantibodies. Tetraspanin 7 is an autoantigen in type 1 diabetes. Tetraspanin 7 autoantibodies are a marker of type 1 diabetes, but provide minor additional value to existing autoantibodies in identifying beta cell autoimmunity.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 24%
Researcher 6 12%
Student > Bachelor 6 12%
Student > Postgraduate 3 6%
Student > Master 3 6%
Other 7 14%
Unknown 12 24%
Readers by discipline Count As %
Medicine and Dentistry 14 29%
Biochemistry, Genetics and Molecular Biology 9 18%
Immunology and Microbiology 4 8%
Agricultural and Biological Sciences 3 6%
Nursing and Health Professions 2 4%
Other 5 10%
Unknown 12 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 December 2016.
All research outputs
#6,696,489
of 24,074,720 outputs
Outputs from Diabetologia
#2,698
of 5,213 outputs
Outputs of similar age
#102,526
of 341,399 outputs
Outputs of similar age from Diabetologia
#39
of 84 outputs
Altmetric has tracked 24,074,720 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 5,213 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.9. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,399 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.